Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01993940 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation
A Phase 3 study, sponsored by Shionogi.
- Completed
- Registry status
- Phase 3
- Development phase
- 553
- Enrollment target
NCT01993940 is a Phase 3 study that has completed, run by Shionogi. The registered enrollment target is 553 participants.
The verdict
NCT01993940, a Phase 3 study, has completed, sponsored by Shionogi.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 553 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy and safety of naldemedine in the treatment of opioid-induced constipation (OIC) in adults with non-malignant chronic pain who are not using laxatives.
Interventions
- DRUG Placebo
- DRUG Naldemedine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 553 participants |
| Start Date | 2013-11-04 |
| Est. Completion | 2015-06-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01993940
The ClinicalTrials.gov registry entry for NCT01993940 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 553 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shionogi, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01993940 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01993940 about?
NCT01993940 is a clinical study titled "Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation". The purpose of this study is to evaluate the efficacy and safety of naldemedine in the treatment of opioid-induced constipation (OIC) in adults with non-malignant chronic pain who are not using laxatives.
What is the current status of trial NCT01993940?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 553 participants. The study started on 2013-11-04. Estimated completion is 2015-06-09.
What interventions are being tested in trial NCT01993940?
The interventions under investigation include: Placebo (DRUG), Naldemedine (DRUG).
Who is sponsoring clinical trial NCT01993940?
This trial is sponsored by Shionogi, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.